Pro-Dex Inc. stock: price, dividend and review in 2026

Pro-Dex stock represents a high-precision medical subcontractor: powered surgical instruments (drills, saws) designed and custom-manufactured for the big equipment makers — steady double-digit growth.

This sheet brings together verified information on Pro-Dex: profile, last three fiscal years’ results, dividend, strengths and risks, then the method for buying the stock on the NASDAQ.

Pro-Dex stock price

Pro-Dex trades on the NASDAQ under the symbol PDEX. The stock follows the programmes of its medical-equipment clients.

Among the other healthcare names covered on this site, Pharnext stock and Quoin Pharmaceuticals Ltd DRC stock also deserve a look.

Pro-Dex stock profile

CompanyPro-Dex, Inc. (surgical instruments, California)
MarketNASDAQ — currency USD (checked on 30/10/2026)
Ticker / SymbolPDEX (NASDAQ)
ISINUS74265M2052
HeadquartersIrvine, California (United States)
SectorHealthcare — powered surgical instruments
Quotation currencyUS dollar (USD)
Fiscal year end30 June
PEA eligibilityNo (issuer domiciled outside the EU/EEA: United States)

Pro-Dex presentation: the operating room’s motor

Custom OEM manufacturing

Pro-Dex designs and manufactures the motors and powered surgical instruments — drills, saws and precision mills — that the big medical-equipment makers then sell under their own brands to operating rooms worldwide. These demanding series (micrometric tolerances, complete traceability required by the FDA, long validations) create high entry barriers and lock in clients for the whole duration of surgical programmes, often a decade or more.

Growth is steady and profitable: $46 million of revenue for fiscal 2023, $54 million for fiscal 2024, $67 million for fiscal 2025 then $78 million for the fiscal year ended June 2026 (+17%) — net income doubles to $14 million.

Near-zero debt, no dividend

Net debt is marginal (under $10 million), the rest of the balance sheet being in cash.

The company pays no dividend: resources finance capacity.

Pro-Dex results and financial data

Pro-Dex almost doubles its profits over two fiscal years, without debt.

IndicatorFY ended June 2024FY ended June 2025FY ended June 2026One-year change
Revenue$53.8m$66.6m$77.5m+16.5%
Net income (group share)$2.1m$9.0m$13.7m+52.1%
Net cash (+) / net debt (−)-$5.1m-$9.3m-$9.1m—

Amounts in millions (m) or billions (bn) of US dollars. Source: S&P Global Market Intelligence via StockAnalysis, company annual reports; data consulted on 23/10/2026.

For the fiscal year ended June 2026, revenue reaches $78 million, up 17%. Net income almost doubles to $14 million. Net debt is marginal. No dividend is paid.

Tableau originalDiversifiez votre patrimoineInvestissez dans l’artDes tableaux originaux, pièces uniques signées par l’artiste. Un actif tangible, loin des écrans et des cotations.Voir les tableaux →

Pro-Dex stock dividend

Pro-Dex pays no dividend.

The expected return therefore comes solely from the price’s evolution.

Should You Buy Pro-Dex Stock in 2026?

Pro-Dex suits healthcare growth investors who accept the illiquidity of a profitable micro-cap.

Strengths

  • OEM subcontracting protected by high regulatory barriers.
  • Continuous double-digit growth, fiscal year after fiscal year.
  • Near debt-free balance sheet.

Risks to watch

  • Pronounced dependence on a few equipment-maker clients.
  • Micro-capitalisation with very low liquidity.
  • Concentration on a small number of client programmes.

The file lends itself to an opportunistic niche growth position in surgical subcontracting.

Fundamental and technical analysis of Pro-Dex

Fundamental analysis

To follow: new client programmes signed, gross margin and portfolio diversification.

Technical analysis

The PDEX chart has risen sharply since 2023, at the pace of double-digit growth.

How to buy Pro-Dex stock?

Pro-Dex stock trades on the NASDAQ, in dollars.

  1. Choose a broker giving access to the NASDAQ: not all cover this market. Compare brokerage and currency fees in our selection of the best stock brokers.
  2. Open an ordinary securities account (the PEA is not available for this non-EU foreign stock), then have your identity verified.
  3. Fund the account by transfer, taking currency-conversion fees into account.
  4. Place the order on the symbol PDEX, preferably with a limit on a foreign stock.

Trading hours and conditions

The NASDAQ trades from 9:30 am to 4:00 pm New York time, i.e. generally 3:30 pm to 10:00 pm in Paris. US stocks can be bought per unit, and some brokers even offer fractional shares. Fill in the W-8BEN form at account opening.

Taxation and currency (France)

Thanks to the W-8BEN form, the US withholding on dividends is reduced to 15%, creditable against French tax. Performance in euros also depends on the dollar’s evolution. (Non-French readers: check your own jurisdiction’s rules.)

Frequently asked questions about Pro-Dex stock

On which exchange is Pro-Dex stock listed?

On the NASDAQ, under the symbol PDEX, in US dollars.

Is Pro-Dex eligible for the PEA?

No. The issuer is American: the stock is held in an ordinary securities account.

Does Pro-Dex pay a dividend?

No dividend is paid: capacity absorbs everything.

What is Pro-Dex’s ISIN code?

The ISIN code is US74265M2052.

What does Pro-Dex manufacture?

Custom-designed powered surgical instruments — drills, saws and precision mills — for the world’s big medical-equipment makers.

Disclaimer: this content is informational and does not constitute investment advice. Investing in the stock market carries a risk of capital loss; past performance is not indicative of future performance.

Suivez-nous sur Telegram